Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1650 to 1699 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1650\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ring finger protein 44. [source:refseq;acc:nm\_014901]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
219.062\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.942\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01445\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1651\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol 3-kinase regulatory alpha subunit (pi3-kinase p85-alpha subunit) (ptdins-3-kinase p85-alpha) (pi3k). [source:swissprot;acc:p27986]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1652\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ring finger protein 38. [source:refseq;acc:nm\_022781]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1653\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol 3-kinase regulatory gamma subunit (pi3-kinase p85-gamma subunit) (ptdins-3-kinase p85-gamma) (p55pik). [source:swissprot;acc:q92569]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1654\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sterol regulatory element binding protein cleavage-activating protein (srebp cleavage-activating protein) (scap). [source:swissprot;acc:q12770]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1655\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase beta chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p06576]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1656\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol 3-kinase regulatory beta subunit (pi3-kinase p85-beta subunit) (ptdins-3-kinase p85-beta). [source:swissprot;acc:o00459]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1657\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage and polyadenylation specific factor 5, 25 kd subunit; pre-mrna cleavage factor im (25kd); pre-mrna cleavage factor im, 25kd subunit. [source:refseq;acc:nm\_007006]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.314\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.195\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01443\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1658\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase alpha chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p25705]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.925\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.826\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1659\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s18a, mitochondrial precursor (mrp-s18-a) (mrps18a) (mrp-s18-3). [source:swissprot;acc:q9nvs2]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1660\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
early endosome antigen 1, 162kd; early endosome-associated protein. [source:refseq;acc:nm\_003566]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
228.654\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.933\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01434\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1661\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate synthase-like 1. [source:refseq;acc:nm\_152328]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.437\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.551\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01432\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1662\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein mrgx (morf-related gene x protein) (mortality factor 4-like 2) (msl3-2 protein). [source:swissprot;acc:q15014]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
228.477\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.747\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01431\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1663\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tryptophan 2,3-dioxygenase (ec 1.13.11.11) (tryptophan pyrrolase) (tryptophanase) (tryptophan oxygenase) (tryptamin 2,3-dioxygenase) (trpo). [source:swissprot;acc:p48775]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.335\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01429\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1664\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein morf4 (mortality factor 4) (cellular senescence-related protein 1) (sen1). [source:swissprot;acc:q9y690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
228.484\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1665\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylosuccinate synthetase (ec 6.3.4.4) (imp--aspartate ligase) (adss) (ampsase). [source:swissprot;acc:p30520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.433\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
201.564\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01423\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1666\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
karyopherin beta 2b, transportin; importin 3. [source:refseq;acc:nm\_013433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.679\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.612\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01422\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1667\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cathepsin b precursor (ec 3.4.22.1) (cathepsin b1) (app secretase). [source:swissprot;acc:p07858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.898\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.898\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01416\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1668\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
survival motor neuron protein (component of gems 1) (gemin1). [source:swissprot;acc:q16637]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
228.496\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
231.729\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01415\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1669\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 1 (p21-rac1) (ras-like protein tc25). [source:swissprot;acc:p15154]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1670\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 3 (p21-rac3). [source:swissprot;acc:o14658]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1671\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoporin 54kda; nucleoporin p54. [source:refseq;acc:nm\_017426]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1672\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 2 (p21-rac2) (small g protein) (gx). [source:swissprot;acc:p15153]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1673\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna replication licensing factor mcm5 (cdc46 homolog) (p1-cdc46). [source:swissprot;acc:p33992]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1674\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
survival of motor neuron protein-interacting protein 1 (smn- interacting protein 1) (component of gems 2) (gemin2). [source:swissprot;acc:o14893]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1675\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent rna helicase ddx20 (dead-box protein 20) (dead- box protein dp 103) (component of gems 3) (gemin3). [source:swissprot;acc:q9uhi6]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1676\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin beta-2 subunit (karyopherin beta-2 subunit) (transportin) (m9 region interaction protein) (mip). [source:swissprot;acc:q92973]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.691\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.645\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01413\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1677\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutathione s-transferase p (ec 2.5.1.18) (gst class-pi) (gstp1-1). [source:swissprot;acc:p09211]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.654\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.732\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01408\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1678\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein kinase 23 (ec 2.7.1.37) (muscle-specific serine kinase 1) (mssk-1). [source:swissprot;acc:q9upe1]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
216.899\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.889\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01407\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1679\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gtp binding protein 2. [source:refseq;acc:nm\_019096]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1680\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 beta (activating transcription factor 6 beta) (atf6-beta) (camp responsive element binding protein-like 1) (camp response element binding protein-related protein) (creb-rp) (g13 protein). [source:swissprot;acc:q99941]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1681\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna segment on chromosome 6(unique) 2654 expressed sequence; dna segment on chromosome x (unique) 2654 expressed sequence. [source:refseq;acc:nm\_012135]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1682\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sfrs protein kinase 2 isoform b. [source:refseq;acc:nm\_182691]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1683\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-6 alpha (activating transcription factor 6 alpha) (atf6-alpha). [source:swissprot;acc:p18850]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1684\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sfrs protein kinase 1; sr protein kinase 1. [source:refseq;acc:nm\_003137]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1685\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
xap-5 protein (hxc-26 protein). [source:swissprot;acc:q14320]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1686\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative sialoglycoprotease type 2. [source:refseq;acc:nm\_022353]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.704\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01399\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1687\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase delta chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p30049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.345\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01393\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1688\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein mrg15 (morf-related gene 15 protein) (mortality factor 4-like 1) (msl3-1 protein) (hspc008/hspc061). [source:swissprot;acc:q9ubu8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
228.523\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.703\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01392\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1689\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead-box protein 4 (vasa homolog). [source:swissprot;acc:q9nqi0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
228.277\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.163\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01383\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1690\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s24 (s19). [source:swissprot;acc:p16632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.091\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.184\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0138\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1691\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor if-2. [source:swissprot;acc:o60841]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.263\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.315\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01376\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1692\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding protein 9 (rna binding motif protein 9) (hexaribonucleotide binding protein 2) (repressor of tamoxifen transcriptional activity). [source:swissprot;acc:o43251]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.515\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.551\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01375\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1693\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inosine-5'-monophosphate dehydrogenase 2 (ec 1.1.1.205) (imp dehydrogenase 2) (impdh-ii) (impd 2). [source:swissprot;acc:p12268]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.937\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.971\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01373\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1694\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gmp synthase [glutamine-hydrolyzing] (ec 6.3.5.2) (glutamine amidotransferase) (gmp synthetase). [source:swissprot;acc:p49915]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1695\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inosine-5'-monophosphate dehydrogenase 1 (ec 1.1.1.205) (imp dehydrogenase 1) (impdh-i) (impd 1). [source:swissprot;acc:p20839]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1696\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 3 (poly(a)-binding protein 3) (pabp 3) (testis-specific poly(a)-binding protein). [source:swissprot;acc:q9h361]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.624\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.69\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01367\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1697\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hskin17 protein. [source:refseq;acc:nm\_012311]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1698\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
carnitine o-acetyltransferase (ec 2.3.1.7) (carnitine acetylase) (cat). [source:swissprot;acc:p43155]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1699\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyadenylate-binding protein 4 (poly(a)-binding protein 4) (pabp 4) (inducible poly(a)-binding protein) (ipabp) (activated-platelet protein-1) (app-1). [source:swissprot;acc:q13310]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/